Hyperuricemia and anemia share several comorbidities, but the association between the two conditions remains unclear. the purpose of this study was to investigate the association between hyperuricemia and anemia. Data of 10794 subjects from the Korean National Health and Nutrition Examination Survey conducted in 2016-2017 were analyzed using multivariate logistic regression analyses. An association between anemia and hyperuricemia was not evident in subjects without chronic kidney disease (cKD). In patients with CKD, anemia increased the risk of hyperuricemia by 2-fold. This association remained significant when adjusting for the glomerular filtration rate. In subgroup analyses, the association of anemia with hyperuricemia was significant in subjects aged ≥65 years, and in those with diabetes or hypertension. Subgroup analyses of cKD patients showed similar results. in the current study using data from Korean representative samples, anemia in subjects with CKD was associated with a 2-fold increase in the risk of hyperuricemia, which remained significant even after adjustment for renal function.
Results
Baseline characteristics of the study population. Of the subjects who participated in the study, 1302 (12.1%) had hyperuricemia. The mean uric acid levels were 7.5 and 4.8 mg/dL in the groups with and without hyperuricemia, respectively. Table 1 shows the general characteristics of the study population with and without hyperuricemia. Subjects with hyperuricemia had a lower glomerular filtration rate and a higher proportion of CKD than those without it. Conversely, the hemoglobin levels were higher in participants with hyperuricemia, and the proportion of anemia was lower. The overall characteristics of the non-CKD subjects, which accounted for most of the participants, were similar to those of the entire population. Unlike subjects without CKD, those with CKD and hyperuricemia were older, less likely to be male, and less educated, although these differences were not statistically significant. There was no statistically significant difference in eGFR according to the presence of hyperuricemia among CKD subjects. In the CKD group, the prevalence of anemia was higher in hyperuricemic subjects (43. 2%) than in non-hyperuricemic subjects (28.6%) .
Association between anemia and hyperuricemia. We performed a multivariate logistic regression analysis to determine the association between anemia and hyperuricemia ( Table 2 ). In non-CKD subjects, the risk of hyperuricemia was significantly lower when anemia was present (OR 0.68 in models adjusted for age, sex, BMI, smoking, alcohol drinking, physical activity, income, and education levels; 95% confidence interval 0.47-0.99), but the difference was not statistically significant when hypertension and diabetes were further adjusted. In CKD subjects, the risk of hyperuricemia was 2-fold higher when anemia was present ( Fig. 1 ). This association persisted, independent of adjustment, and remained significant even after adjustment of eGFR, a value representing the degree of renal function. When CKD was analyzed in two groups based on an eGFR of 30 mL/min/1.73 m 2 , the statistical significance of the association between anemia and hyperuricemia was maintained in CKD stage 3 group (eGFR 30-60 mL/min/1.73 m 2 ). In the group with CKD less than stage 2 (eGFR < 30 mL/min/1.73 m 2 ), anemia and hyperuricemia tended to correlate, although the small number of patients did not allow us to obtain statistical significance ( Supplementary Table S1 ).
Subgroup analyses were performed to determine whether the association between anemia and hyperuricemia varies according to participant characteristics (Fig. 2) . The association between anemia and hyperuricemia was evident in subjects aged ≥65 years, in those with diabetes, and in those with hypertension.
In the subgroup analyses of CKD patients, the association between anemia and hyperuricemia remained significant in most subgroups, although this association was more pronounced in older and in hypertensive patients ( Fig. 3 ).
Discussion
In this study, we analyzed the association between anemia and hyperuricemia using representative sample data from the noninstitutionalized civilian Korean population. The association between anemia and hyperuricemia was distinct depending on the presence of CKD. In subjects with CKD, the risk of hyperuricemia was doubled in the presence of anemia, and this association remained significant after adjustment for renal function. In those without CKD, anemia and hyperuricemia were inversely correlated. The association between anemia and hyperuricemia varied depending upon the characteristics of the subjects. Anemia increased the risk of hyperuricemia in people aged ≥65 years, and in those with diabetes or hypertension. In CKD subjects, anemia generally increased the risk of hyperuricemia, but the association was more pronounced in older and in hypertensive participants.
The baseline characteristics of the study population according to the presence of hyperuricemia were significantly different between the CKD and non-CKD groups. Sex, alcohol consumption, physical activity, hypertension, hyperlipidemia and obesity, which are well known risk factors of hyperuricemia, differed in the presence of hyperuricemia in the non-CKD group but not in the CKD group 8, [16] [17] [18] . These results indicated that CKD itself is the most important factor in the development of hyperuricemia in CKD patients.
Unlike other variables, which showed no significant differences in the CKD group, anemia had significantly higher prevalence in hyperuricemic subjects than in non-hyperuricemic subjects. In a multivariate logistic regression analysis that examined the association between anemia and hyperuricemia, anemia was associated with a 2-fold increase in the risk of hyperuricemia in CKD subjects. We propose two possible explanations for these things. First, anemia is more common in patients with advanced stages of CKD, and hyperuricemia is more common as CKD progresses, which may explain the coexistence of hyperuricemia and anemia as a result of poor renal function [19] [20] [21] . However, a significant association between anemia and hyperuricemia even after adjustment for eGFR, representing renal function, suggests that there is a direct relationship between the two conditions, and not that they are merely coexisting conditions due to deterioration of renal function. Second, anemia leads to an increase in oxidative stress, which may result in hyperuricemia. Several studies have reported high oxidative stress levels in patients with renal disease [22] [23] [24] . Oxidative stress affects the cellular structure and function of erythrocytes and is involved in the development of anemia 24 . Conversely, anemia itself in CKD patients may increase oxidative stress. This has been indirectly demonstrated by studies in which serum levels of aldehydic lipid peroxidation products were reduced when renal anemia was corrected through erythropoietin treatment 25 . Hypoxia and impaired oxidative metabolism are associated with elevated uric acid levels 26, 27 . Hypoxia induces accumulation of the uric acid precursors hypoxanthine and xanthine, activating xanthine dehydrogenase and xanthine oxidase 28, 29 .
The number of CKD patients included in this study is much smaller than the number of non-CKD subjects. According to a study on CKD prevalence in Korea, the prevalence of CKD above stage 3, corresponding to the CKD definition of glomerular filtration rate <60 mL/min/1.73 m 2 , was 2.5%, which is lower than the global mean prevalence of 10.6% calculated from meta-analysis 30, 31 . The prevalence of CKD in this study was about 3.2%, which reflects the prevalence of the general Korean population. Despite the small number of CKD patients, a clear association between hyperuricemia and anemia was identified.
The results of this study showed that anemia and hyperuricemia are inversely correlated in non-CKD subjects, contrary to that in CKD subjects. This may reflect nutritional status. In hyperuricemic subjects, higher energy intake, higher BMI, and higher obesity prevalence than non-hyperuricemic subjects appeared to indicate Total (n = 10794) Non-CKD (n = 10455) CKD (n = 341) that hyperuricemic subjects had better nutrition than non-hyperuricemic subjects 32 . Since malnutrition is an important factor contributing to the development of anemia, such differences in nutrition may have affected the inverse correlation between hyperuricemia and anemia 33, 34 . Alcohol consumption has opposite effect on anemia and hyperuricemia, which negatively affects anemia but increases hyperuricemia [35] [36] [37] . Considering that obesity is associated with chronic, low-grade inflammation, the prevalence of anemia of inflammation may be higher in obese persons 38, 39 . A study of 14848 NHANES III participants in the US confirmed that overweight and obese persons did not have a higher prevalence of anemia than normal-weight persons 40 . The pathogenesis of anemia of inflammation contributes to dysregulation of iron homeostasis, impaired proliferation of erythroid progenitor cells, and blunted erythropoietin response 41 . Obesity can cause hypoferremia owing to changes in iron homeostasis but does not affect red-cell survival or erythropoiesis 42 . Therefore, the prevalence of anemia of inflammation may not be high in obese persons. Elevation of erythropoietin levels associated with hypoxia due to obstructive sleep apnea whose incidence increases in obesity or cellular hypoxia due to adipose tissue expansion in obese persons may also be possible explanations 43, 44 . www.nature.com/scientificreports www.nature.com/scientificreports/ In the non-CKD group, individuals with hyperuricemia were younger and more physically active and had higher C-reactive protein levels than those without. The link between inflammation and uric acid has been demonstrated in previous studies [45] [46] [47] . Regardless of hyperuricemia being a cause or a consequence of inflammation, this study cannot clearly identify causal relationships due to the limitations of cross-sectional studies. However, it is reasonable to understand that hyperuricemia induces inflammation based on the recent report that proinflammatory NF-KB signaling pathway was activated when human hepatoma HepG2 cells were exposed to uric acid 45 .
The difference in the association between anemia and hyperuricemia according to presence of CKD may be due to differences in the mechanism of anemia with or without CKD. Anemia observed in CKD is attributed to various factors such as decreased erythropoietin production, shortened erythrocyte life span, inflammation, and increased blood loss 48 . According to a systemic analysis of global anemia burden from 1990 to 2010, the most common type of anemia was iron deficiency anemia 14 . Subsequently, iron deficiency anemia may be the most common type in non-CKD subjects, which accounts for most of the population of this study. In previous studies, positive correlations between ferritin, iron, and serum urate levels have been demonstrated 49, 50 . Therefore, hyperuricemia is less likely to occur with anemia in non-CKD subjects, in whom iron deficiency anemia is a major component. In addition, as described earlier, CKD itself plays an important role in increasing oxidative stress, so that oxidative stress induced by anemia in non-CKD patients may be insufficient to cause hyperuricemia.
In subgroup analyses, the association between anemia and hyperuricemia was more pronounced in older subjects, and in subjects with hypertension or diabetes. Old age, hypertension, and diabetes are variables associated with anemia and hyperuricemia 1,10,51-54 . Therefore, the prevalence of hyperuricemia and anemia may be higher in patients with these characteristics. In the subgroup analysis of CKD subjects, the association between anemia and hyperuricemia was clearly observed, regardless of the characteristics of the subjects. However, this association was more evident in older subjects, and in those with hypertension.
There are several limitations to our study. First, this was a cross-sectional study. Hence although the association between anemia and hyperuricemia could be confirmed, a causal relationship cannot be verified. Second, since KNHANES did not contain detailed information about underlying diseases that might affect anemia or medication taken by subjects, we could not adjust for treatment of anemia or hyperuricemia in analyses. Third, the causes of anemia vary, but KNHANES does not include information such as erythropoietin level, iron state, or vitamin B12 level, which can be used to identify the cause of anemia. Therefore, no analysis of the association of hyperuricemia with the cause of anemia was performed in this study. Fourth, the small number of CKD patients did not allow discrimination between CKD stages. Although eGFR was adjusted to reflect the renal function, further studies including more CKD patients are needed to determine whether the association between anemia and hyperuricemia will increase as the CKD stage progresses. Finally, the prevalence of anemia and hyperuricemia may vary according to race or characteristics of the subjects, thus generalizability may be limited in applying the results of this study. Further studies are needed to confirm whether the relationship between anemia and hyperuricemia is maintained in a population of different races or characteristics and to identify the mechanism by which anemia contributes to hyperuricemia. Despite these limitations, this study is valuable because it suggests a direct association between hyperuricemia and anemia.
Using data from Korean representative samples, anemia in CKD subjects is associated with a 2-fold increase in the risk of hyperuricemia compared to that in non-CKD subjects. And this association remains significant even after adjustment for renal function. These results demonstrate that the two conditions may have a direct relationship, and are not merely coexisting conditions. 
